All Stories

  1. Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up

    Article • Cardiology Research and Practice, December 2019, Hindawi Publishing Corporation

    Clément Delmas, Dr laurent bonello

  2. Bivalirudin during percutaneous coronary intervention in acute coronary syndromes

    Article • Expert Opinion on Pharmacotherapy, December 2018, Taylor & Francis

    Dr laurent bonello

  3. Mechanical Support in Cardiogenic Shock Complicating Acute Coronary Syndrome: Ready for Prime Time?

    Article • Current Vascular Pharmacology, July 2018, Bentham Science Publishers

    Dr laurent bonello

  4. Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome

    Article • Platelets, November 2017, Taylor & Francis

    Dr laurent bonello

  5. Anthraquinones, the Dr Jekyll and Mr Hyde of the food pigment family

    Article • Food Research International, November 2014, Elsevier

    Dr laurent bonello, Prof Dr Laurent Dufossé

  6. COMparison ofPlatelet reactivity following prAsugrel and ticagrelor loading dose inST-Segment elevation myocardial infarctIONpatients: The COMPASSION study

    Article • Platelets, October 2014, Taylor & Francis

    Dr laurent bonello

  7. Reply

    Article • Journal of the American College of Cardiology, June 2014, Elsevier

    Dr laurent bonello

  8. Oral anticoagulant treatment in geriatric patients with nonvalvular atrial fibrillation in the era of direct oral anticoagulant agents

    Article • European Journal of Internal Medicine, June 2014, Elsevier

    Dr laurent bonello

  9. Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients

    Article • International Journal of Cardiology, April 2014, Elsevier

    Dr laurent bonello

  10. Vasodilator‐Stimulated Phosphoprotein (VASP) Assay

    Article • March 2014, Wiley

    Dr laurent bonello

  11. Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome

    Article • Journal of the American College of Cardiology, March 2014, Elsevier

    Dr laurent bonello

  12. With Age Comes Wisdom

    Article • Journal of the American College of Cardiology, February 2014, Elsevier

    Dr laurent bonello

  13. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Dr laurent bonello, Professor Jolanta M Siller-Matula

  14. Impact of initial clinical presentation on clopidogrel low response

    Article • Archives of Cardiovascular Diseases, November 2013, Elsevier

    Dr laurent bonello

  15. Assessing post-treatment platelet reactivity: a focus on patient selection and setting

    Article • Expert Review of Cardiovascular Therapy, November 2013, Taylor & Francis

    Dr laurent bonello

  16. Poor agreement between light transmission aggregometry, Verify Now P2Y12and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: A potential explanation of negative results of recent randomized trials

    Article • Platelets, October 2013, Taylor & Francis

    Dr laurent bonello

  17. Comparison of Bivalirudin Versus Heparin(s) During Percutaneous Coronary Interventions in Patients Receiving Prasugrel: A Propensity‐Matched Study

    Article • Clinical Cardiology, October 2013, Wiley

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli, Dr laurent bonello

  18. Ticagrelor or prasugrel for pre-hospital protocols in STEMI?

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr laurent bonello

  19. A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr laurent bonello

  20. The safety of cardiac resynchronization therapy pacemaker implantation in octogenarians: A monocentric experience

    Article • International Journal of Cardiology, October 2013, Elsevier

    Dr laurent bonello

  21. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Marco Valgimigli, Associate Prof Hasan Ari, Dr laurent bonello

  22. Improved biological efficacy of prasugrel one month after an acute coronary syndrome

    Article • International Journal of Cardiology, September 2013, Elsevier

    Dr laurent bonello

  23. Current evidence for monitoring platelet reactivity in acute coronary syndrome: A plea for individualized antiplatelet treatment

    Article • International Journal of Cardiology, September 2013, Elsevier

    Dr laurent bonello

  24. The Impact of the Environment on Diseases and Drugs

    Article • Journal of the American College of Cardiology, August 2013, Elsevier

    Dr laurent bonello

  25. Using risk difference as opposed to odds-ratio in meta-analysis. Response

    Article • International Journal of Cardiology, June 2013, Elsevier

    Dr laurent bonello

  26. Adherence to protocol and determinants in ST-elevation myocardial infarction

    Article • International Journal of Cardiology, June 2013, Elsevier

    Dr laurent bonello

  27. Biological efficacy and clinical safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: A pilot study

    Article • International Journal of Cardiology, April 2013, Elsevier

    Dr laurent bonello

  28. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: Results of the randomized Intra-Co-EpoMI trial

    Article • Archives of Cardiovascular Diseases, March 2013, Elsevier

    Dr laurent bonello

  29. Pharmacological Interactions

    Article • JACC Cardiovascular Interventions, February 2013, Elsevier

    Dr laurent bonello

  30. Diagnostic Performance of Computed Tomography Coronary Angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)

    Article • The American Journal of Cardiology, February 2013, Elsevier

    Dr laurent bonello

  31. Ticagrelor: the silence of the platelets

    Article • Expert Opinion on Pharmacotherapy, January 2013, Informa Healthcare

    Dr laurent bonello

  32. Tailoring Antiplatelet Therapy

    Article • Circulation Journal, January 2013, Japanese Circulation Society

    Dr laurent bonello

  33. 009: Comparison of bleeding complications and three-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction. The FAST-MI registry

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Dr laurent bonello

  34. 025: Impact of initial clinical presentation on clopidogrel low response: is there any intra-individual variability over time?

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Dr laurent bonello

  35. 021: Clopidogrel low response and correlation between the different tests: light transmission aggregometry, VerifyNow-P2Y12 and V ASP

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Dr laurent bonello

  36. 056: Biological efficacy of a 600mg loading dose of clopidogrel in ST-elevation myocardial infarction

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Dr laurent bonello

  37. 232: Mobilization of CD34+KDR+ cells among circulating progenitors predicts target lesion revascularization

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Dr laurent bonello

  38. 039: Platelet reactivity predicts both ischemic and bleeding events at one year follow-up in acute coronary syndome patients receiving prasugrel

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Dr laurent bonello

  39. Clinical Impact of Genetically Determined Platelet Reactivity

    Article • Journal of Cardiovascular Translational Research, November 2012, Springer Science + Business Media

    Dr laurent bonello

  40. TCT-747 Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Marco Valgimigli, Associate Prof Hasan Ari, Dr laurent bonello

  41. TCT-737 Relationship between post treatment platelet reactivity and ischemic and bleeding events at one year follow-up in acute coronary syndrome patients receiving prasugrel

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Dr laurent bonello

  42. Tailoring Antiplatelet Therapy: A Step Toward Individualized Therapy to Improve Clinical Outcome?

    Article • Current Pharmaceutical Design, September 2012, Bentham Science Publishers

    Dr laurent bonello

  43. Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade

    Article • Thrombosis Research, July 2012, Elsevier

    Dr laurent bonello

  44. Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: The FAST-MI registry

    Article • Archives of Cardiovascular Diseases, June 2012, Elsevier

    Dr laurent bonello

  45. Latest Evidence in Personalized Antiplatelet Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

    Article • Hospital Practice, April 2012, Taylor & Francis

    Dr laurent bonello

  46. High on Treatment Platelet Reactivity

    Article • Heart Lung and Circulation, January 2012, Elsevier

    Dr laurent bonello

  47. 021 Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

    Article • Archives of Cardiovascular Diseases Supplements, January 2012, Elsevier

    Dr laurent bonello

  48. Rate of Nuisance Bleedings and Impact on Compliance to Prasugrel in Acute Coronary Syndromes

    Article • The American Journal of Cardiology, December 2011, Elsevier

    Dr laurent bonello

  49. Platelets and endothelium: Two key players in percutaneous coronary intervention

    Article • Archives of Cardiovascular Diseases, December 2011, Elsevier

    Dr laurent bonello

  50. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation

    Article • Archives of Cardiovascular Diseases, October 2011, Elsevier

    Dr laurent bonello

  51. Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation: A Review of the Current Guidelines and Literature

    Article • Hospital Practice, October 2011, Taylor & Francis

    Dr laurent bonello

  52. Genotypic and Phenotypic Assessment of Platelet Function and Response to P2Y12 Antagonists

    Article • Current Cardiology Reports, July 2011, Springer Science + Business Media

    Dr laurent bonello

  53. Personalized Antiplatelet Therapy: Review of the Latest Clinical Evidence

    Article • Current Cardiology Reports, May 2011, Springer Science + Business Media

    Dr laurent bonello

  54. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

    Article • EuroIntervention, April 2011, Europa Digital & Publishing

    Dr laurent bonello

  55. Impact of loading dose adjustment on platelet reactivity in homozygotes of the 2C19 2⁎ loss of function polymorphism

    Article • International Journal of Cardiology, November 2010, Elsevier

    Dr laurent bonello

  56. Clopidogrel Loading Dose Adjustment According to Platelet Reactivity Monitoring in Patients Carrying the 2C19*2Loss of Function Polymorphism

    Article • Journal of the American College of Cardiology, November 2010, Elsevier

    Dr laurent bonello

  57. Usefulness of basal B-type natriuretic peptide levels for the diagnosis of diastolic heart failure in young patients: An echocardiographic-catheterization study

    Article • International Journal of Cardiology, November 2010, Elsevier

    Dr laurent bonello

  58. Accuracy of Doppler-derived pulmonary artery hypertension to predict heart failure with normal ejection fraction

    Article • International Journal of Cardiology, November 2010, Elsevier

    Dr laurent bonello

  59. Usefulness of left atrial volume for the diagnosis of diastolic heart failure: An echocardiographic-catheterization study

    Article • International Journal of Cardiology, October 2010, Elsevier

    Dr laurent bonello

  60. Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents

    Article • International Journal of Cardiology, September 2010, Elsevier

    Dr laurent bonello

  61. Level of Adenosine Diphosphate Receptor P2Y12 Blockade During Percutaneous Coronary Intervention Predicts the Extent of Endothelial Injury, Assessed by Circulating Endothelial Cell Measurement

    Article • Journal of the American College of Cardiology, September 2010, Elsevier

    Dr laurent bonello

  62. Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Article • Journal of the American College of Cardiology, September 2010, Elsevier

    Dr laurent bonello

  63. Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention

    Article • Thrombosis Research, August 2010, Elsevier

    Dr laurent bonello

  64. Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy

    Article • Platelets, July 2010, Taylor & Francis

    Dr laurent bonello

  65. Relationship between platelet reactivity inhibition and major bleeding in patients undergoing percutaneous coronary intervention

    Article • Cardiovascular Revascularization Medicine, July 2010, Elsevier

    Dr laurent bonello

  66. Early and late outcomes of clopidogrel and Coumadin combination for patients on oral anticoagulants undergoing coronary stenting

    Article • Cardiovascular Revascularization Medicine, July 2010, Elsevier

    Dr laurent bonello

  67. Dosing Strategies for Antiplatelet Therapy in Percutaneous Coronary Intervention

    Article • Hospital Practice, April 2010, Taylor & Francis

    Dr laurent bonello

  68. Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients

    Article • Thrombosis Research, April 2010, Elsevier

    Dr laurent bonello

  69. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: An echocardiographic-catheterization study

    Article • Archives of Cardiovascular Diseases, January 2010, Elsevier

    Dr laurent bonello

  70. Personalised Antiplatelet Therapy – Whether to Choose Genotype or Phenotype

    Article • European Cardiology Review, January 2010, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Dr laurent bonello

  71. 106 Determinants of B-type natriuretic peptide levels and left atrial volume in stable patients in sinus rhythm: an echocardiographic-catheterization study

    Article • Archives of Cardiovascular Diseases Supplements, January 2010, Elsevier

    Dr laurent bonello

  72. A social network analysis of health care professional relationships in a French hospital

    Article • International Journal of Health Care Quality Assurance, January 2010, Emerald

    Dr laurent bonello

  73. Relation of Body Mass Index to High On-Treatment Platelet Reactivity and of Failed Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients Undergoing Percutaneous Coronary Intervention

    Article • The American Journal of Cardiology, December 2009, Elsevier

    Dr laurent bonello

  74. Personalized antiplatelet therapy for coronary artery disease patients: is this the future?

    Article • Expert Review of Cardiovascular Therapy, December 2009, Taylor & Francis

    Dr laurent bonello

  75. Response to "Myocardial infarction in saphenous percutaneous intervention: Are we really doing our best?"

    Article • American Heart Journal, September 2009, Elsevier

    Dr laurent bonello

  76. Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

    Article • Catheterization and Cardiovascular Interventions, August 2009, Wiley

    Dr laurent bonello

  77. Prevalence of Aspirin and Clopidogrel Resistance Among Patients With and Without Drug-Eluting Stent Thrombosis

    Article • The American Journal of Cardiology, August 2009, Elsevier

    Dr laurent bonello

  78. Elevated circulating endothelial progenitor cells in stent thrombosis patients is not correlated with platelet reactivity index

    Article • Cardiovascular Revascularization Medicine, July 2009, Elsevier

    Dr laurent bonello

  79. Lack of prognostic value of pre-procedural HbA1C in diabetic patients undergoing percutaneous coronary intervention with drug-eluting stent implantation

    Article • Cardiovascular Revascularization Medicine, July 2009, Elsevier

    Dr laurent bonello

  80. Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation

    Article • The American Journal of Cardiology, July 2009, Elsevier

    Dr laurent bonello

  81. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty

    Article • Cardiovascular Revascularization Medicine, July 2009, Elsevier

    Dr laurent bonello

  82. Is there a rebound effect after clopidogrel discontinuation in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation?

    Article • Cardiovascular Revascularization Medicine, July 2009, Elsevier

    Dr laurent bonello

  83. Clinical Manifestation and Prognosis of Early versus Late Stent Thrombosis of Drug‐Eluting Stents

    Article • Journal of Interventional Cardiology, May 2009, Wiley

    Dr laurent bonello

  84. Incidence, Predictors, and Outcome of New, Subsequent Lesions Treated With Percutaneous Coronary Intervention in Patients Presenting With Myocardial Infarction

    Article • The American Journal of Cardiology, May 2009, Elsevier

    Dr laurent bonello

  85. Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions

    Article • American Heart Journal, May 2009, Elsevier

    Dr laurent bonello

  86. Requirement for Emergent Coronary Artery Bypass Surgery Following Percutaneous Coronary Intervention in the Stent Era

    Article • The American Journal of Cardiology, April 2009, Elsevier

    Dr laurent bonello

  87. Paclitaxel‐eluting balloon: From bench to bed

    Article • Catheterization and Cardiovascular Interventions, March 2009, Wiley

    Dr laurent bonello

  88. Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three‐vessel coronary artery disease

    Article • Catheterization and Cardiovascular Interventions, March 2009, Wiley

    Dr laurent bonello

  89. Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation

    Article • The American Journal of Cardiology, March 2009, Elsevier

    Dr laurent bonello

  90. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: Comparison between drug-eluting stents and bare-metal stents

    Article • Archives of Cardiovascular Diseases, March 2009, Elsevier

    Dr laurent bonello

  91. Racial Disparities in Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stents

    Article • The American Journal of Cardiology, March 2009, Elsevier

    Dr laurent bonello

  92. Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery

    Article • The American Journal of Cardiology, March 2009, Elsevier

    Dr laurent bonello

  93. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy

    Article • Catheterization and Cardiovascular Interventions, February 2009, Wiley

    Dr laurent bonello

  94. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice

    Article • Archives of Cardiovascular Diseases, February 2009, Elsevier

    Dr laurent bonello

  95. Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

    Article • Journal of Interventional Cardiology, February 2009, Wiley

    Dr laurent bonello

  96. Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents

    Article • The American Journal of Cardiology, February 2009, Elsevier

    Dr laurent bonello

  97. Comparison of Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in Nonostial Proximal Left Anterior Descending Coronary Arteries

    Article • The American Journal of Cardiology, February 2009, Elsevier

    Dr laurent bonello

  98. Actinomycose cardiaque

    Article • January 2009, Springer Science + Business Media

    Dr laurent bonello

  99. Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis

    Article • The American Journal of Cardiology, January 2009, Elsevier

    Dr laurent bonello

  100. Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation

    Article • The American Journal of Cardiology, December 2008, Elsevier

    Dr laurent bonello

  101. Vascular Brachytherapy for Patients with Drug‐Eluting Stent Restenosis

    Article • Journal of Interventional Cardiology, November 2008, Wiley

    Dr laurent bonello

  102. Stent thrombosis in 2008: Definition, predictors, prognosis and treatment

    Article • Archives of Cardiovascular Diseases, November 2008, Elsevier

    Dr laurent bonello

  103. Impact of a 600-mg Loading Dose of Clopidogrel on 30-Day Outcome in Unselected Patients Undergoing Percutaneous Coronary Intervention

    Article • The American Journal of Cardiology, November 2008, Elsevier

    Dr laurent bonello

  104. Comparison of Safety, Efficacy, and Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in “True” Chronic Total Occlusions

    Article • The American Journal of Cardiology, November 2008, Elsevier

    Dr laurent bonello

  105. Reply

    Article • Journal of the American College of Cardiology, October 2008, Elsevier

    Dr laurent bonello

  106. Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study

    Article • International Journal of Cardiology, October 2008, Elsevier

    Dr laurent bonello

  107. Impact of Optimal Medical Therapy and Revascularization on Outcome of Patients With Chronic Kidney Disease and on Dialysis Who Presented With Acute Coronary Syndrome

    Article • The American Journal of Cardiology, September 2008, Elsevier

    Dr laurent bonello

  108. Reply

    Article • Journal of the American College of Cardiology, August 2008, Elsevier

    Dr laurent bonello

  109. Ventricular arrhythmias during Tako-tsubo syndrome

    Article • International Journal of Cardiology, August 2008, Elsevier

    Dr laurent bonello

  110. The 5 Ts of Bifurcation Intervention: Type, Technique, Two Stents, T-Stenting, Trials

    Article • JACC Cardiovascular Interventions, August 2008, Elsevier

    Dr laurent bonello

  111. Bivalirudin With Provisional Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Angioplasty in the Setting of Cardiogenic Shock

    Article • The American Journal of Cardiology, August 2008, Elsevier

    Dr laurent bonello

  112. Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)

    Article • The American Journal of Cardiology, August 2008, Elsevier

    Dr laurent bonello

  113. Bleeding Risk and Outcomes of Bivalirudin Versus Glycoprotein IIb/IIIa Inhibitors With Targeted Low-Dose Unfractionated Heparin in Patients Having Percutaneous Coronary Intervention for Either Stable or Unstable Angina Pectoris

    Article • The American Journal of Cardiology, July 2008, Elsevier

    Dr laurent bonello

  114. Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance

    Article • Journal of the American College of Cardiology, April 2008, Elsevier

    Dr laurent bonello

  115. Auguste Laurent (1807-1853) dans la Revue scientifique du Dr Quesneville

    Article • Revue d histoire de la pharmacie, January 2008, PERSEE Program

    Dr laurent bonello

  116. Mueller polarimetric imaging system with liquid crystals

    Article • Applied Optics, May 2004, Optical Society of America (OSA)

    Dr laurent bonello

  117. HLA-DR 7 in Adult Lipoid Nephrosis Patients

    Article • January 1983, Karger Publishers

    Dr laurent bonello

  118. Studies of HLA-DR Antigens by Complement Fixation

    Article • January 1981, Springer Science + Business Media

    Dr laurent bonello